openPR Logo
Press release

Vaginal Rings Market Latest Report with Current Industry Impact Analysis | Millicent Pharma, Merck & Co., Inc., Pfizer Inc., TherapeuticsMD, Inc., Amneal Pharmaceuticals, Inc.

06-09-2020 02:26 PM CET | Health & Medicine

Press release from: Bizlytik Intelligence & Technologies

Vaginal Rings Market was valued at $1,746.4 million by 2019; growing at a CAGR of 3.5% till 2026.

In terms of volume, the vaginal ring's market was valued at 4,318.3 K Units in 2019; witnessing a CAGR of 2.1% from 2020 to 2026.

The vaginal ring is a flexible, small, plastic ring, which is inserted in the vagina to prevent pregnancy. The vaginal ring prevents pregnancy by continuously releasing hormones estrogen and progestin. The vaginal ring thickens the cervical mucus, which makes it difficult for sperm to move through the cervix and reduce the lining of the womb so that fertilized egg does not implant itself.

Browse More Details at: https://bizlytik.com/report/vaginal-rings-market/#overview

Rising prevalence of menopausal and polycystic ovary syndrome (PCOS) is a key driving factor of the market. According to the World Health Organization (WHO), The average age of menopause is 51 years, but menopause can occur earlier. Around 1.2 billion women worldwide are expected to have menopausal or postmenopausal by the year 2030. Approximately 85% of postmenopausal women have experienced menopause-related symptoms in their lifetime. About 75% of women suffer from hot flashes during menopause. According to the Society of Obstetricians and Gynecologists of Canada, 80% of women suffer from menopausal symptoms including irritability, interrupted sleep, hot flushes mood swings, or vaginal dryness. According to the Centers for Disease Control and Prevention, polycystic ovary syndrome (PCOS) is one of the common causes of female infertility, affecting 6% to 12% of US women of reproductive age, which is 5 million women. The vaginal hormone ring helps to lower the hormone levels in girls with polycystic ovary syndrome (PCOS). The vaginal ring releases estrogen to help relieve moderate to severe symptoms of postmenopausal vaginal.

Nuvaring, Femring, and Estring is the type segment of the market scope. By sales channels, the market is divided into Hospitals and Clinics, Pharmacy, and Online Pharmacy. The report covers the value of the global market by type and sales channels.

Get the inside scoop of the Sample report @: https://bizlytik.com/report/vaginal-rings-market/#request-for-sample

Nuvaring was dominating the global vaginal rings market in 2019, owing to a partnership between companies for license and commercialization agreement to develop and market a generic version of NuvaRing product, and increasing approval of the generic version of NuvaRing.

North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global vaginal rings value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global vaginal rings market in 2019, due to the rising prevalence of menopausal and polycystic ovary syndrome (PCOS), the partnership between companies to develop and market vaginal rings, and commercialization of regulatory approved virginal rings.

Major players operating in the vaginal rings industry include Millicent Pharma, Merck & Co., Inc., Pfizer Inc., TherapeuticsMD, Inc., Amneal Pharmaceuticals, Inc., and Johnson & Johnson.

Commercialization of regulatory approved virginal rings, increasing clinical studies on vaginal rings, and partnership between companies to develop and market vaginal rings are some of the strategies adopted by the major companies.

Request for Report Customization @ https://bizlytik.com/media-release/vaginal-rings-market/#customization

Vaginal Rings Market Key Segments:

By Type
• Nuvaring
• Femring
• Estring

By Sales Channel
• Hospitals and Clinics
• Pharmacy
• Online Pharmacy

Key Global Vaginal Rings Industry Players
• Millicent Pharma
• Merck & Co., Inc.
• Pfizer Inc.
• TherapeuticsMD, Inc.
• Amneal Pharmaceuticals, Inc.
• Johnson & Johnson

Contact US
Bizlytik Intelligence & Technologies
E-mail: Sales@bizlytik.com
Tel: +1-816-203-2828
Web: https://bizlytik.com
Address:
107 W. 9th Street, 2nd Floor, Kansas City, Missouri, 64105, United States of America

About Us
Bizlytik is a market research and consulting firm which operates in the business to business research space. We provide qualitative and quantitative research reports for all the major industry domains to clients across the globe. Bizlytik is one of the leading provider of global business intelligence which includes, market, product, consumer, competitor, and vendor information along with insightful analysis.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaginal Rings Market Latest Report with Current Industry Impact Analysis | Millicent Pharma, Merck & Co., Inc., Pfizer Inc., TherapeuticsMD, Inc., Amneal Pharmaceuticals, Inc. here

News-ID: 2070549 • Views:

More Releases from Bizlytik Intelligence & Technologies

IT & Telecom companies turning to Cyber Security Insurance policies to insure ag …
Cyber Security Insurance Market is expected to reach USD 28,362.7 million by the end of 2026. Bizlytik analysts forecast the Global Cyber Security Insurance market to grow at a CAGR of 24.5% during the forecast period, according to their latest market research report. Request a Free Sample Report @ https://bizlytik.com/media-release/cyber-security-insurance-market/#customization Cyber Security Insurance deals with policies that safeguard companies financially against potential security breaches and data theft attempts. The plans alleviate risk exposure
Medical Ultrasound Probe Cover Market Size, Share, Growth & Forecast By 2026
Medical Ultrasound Probe Cover Market is expected to grow at a significant CAGR from 2020 to 2026. Ultrasound probe cover is also known as transducer cover. Ultrasound probe cover is used to protects patients and professionals against cross-contamination and the risk of healthcare-associated infections. Ultrasound probe covers are used for anesthesia, radiology, breast surgeons, cardiology, gynaecology, urology, gastroenterology, and others application. Ultrasound probe cover reduces the costs for maintenance and disinfection
COVID-19 Impact and Recovery Analysis- Single-use Technologies for Biopharmaceut …
Single-use technologies for biopharmaceuticals market was valued at $3,489.0 million by 2019; growing at a CAGR of 11.7% till 2026. The biopharmaceutical industry is rapidly adopting Single-use technologies for bioprocessing to reduce the risk of cross-contamination. Single-use bioprocessing equipment is designed to be used once. The Single-use bioprocessing equipment is primarily composed of plastic components that have been sealed and sterilized using gamma irradiation. Single-use technology in biopharmaceutical industry includes bioreactors,
SaaS-based pay-per-use models to become essential components of Cloud Management …
Cloud Management Platform (CMP) market is expected to reach USD 21,068.5 million by the end of 2026. Bizlytik analysts forecast the global Cloud Management Platform (CMP) market to grow at a CAGR of 20.4% during the forecast period, according to their latest market research report. Cloud Management Platform solutions are designed to assist in the monitoring and control of several cloud-based computing services of an organization. The software tools can also generate

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the